Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 53

Sort by

Sort Order Select

Journal Articles

Validation of Angioimmunoblastic T-Cell Lymphoma (AITL) Score in Korean AITL Patients

Bohyun Moon, Hyungwoo Cho, Changhoon Yoo, Hyung-Don Kim, Shin Kim, Jin Sook Ryu, Jooryung Huh, Chan-Sik Park, Sang-wook Lee, Yoon Sei Lee, Cheolwon Suh

Blood (2022) 140 (Supplement 1): 12011–12012.

https://doi.org/10.1182/blood-2022-157415

Published: 2022

Journal Articles

Prognostic Stratification of Patients with Primary Central Nervous System Lymphoma Using Serum β 2 -Microglobulin Levels

Yeokyeong Shin, Hyungwoo Cho, Shin Kim, Hyung-Don Kim, Jin-Sook Ryu, Jooryung Huh, Chan-Sik Park, Sang-wook Lee, Cheolwon Suh

Blood (2022) 140 (Supplement 1): 9496–9497.

https://doi.org/10.1182/blood-2022-163029

Published: 2022

Journal Articles

Central Nervous System Relapse in Patients with Extranodal NK/T-Cell Lymphoma, Nasal Type

Hyehyun Jeong, MD, Jung Yong Hong, Dok Hyun Yoon, Shin Kim, Jung Sun Park, Sang Wook Lee, Chan Sik Park, MD, Jin-Sook Ryu, Jooryung Huh, Cheolwon Suh

Blood (2018) 132 (Supplement 1): 1634.

https://doi.org/10.1182/blood-2018-99-120137

Published: 2018

Journal Articles

Central Nervous System Relapse in Patients with Peripheral T-Cell Lymphoma

Hyehyun Jeong, MD, Jung Yong Hong, Dok Hyun Yoon, Shin Kim, Jung Sun Park, Sang Wook Lee, Chan Sik Park, MD, Jin-Sook Ryu, Jooryung Huh, Cheolwon Suh

Blood (2018) 132 (Supplement 1): 5346.

https://doi.org/10.1182/blood-2018-99-119980

Published: 2018

Journal Articles

Prognostic Value of Serum Beta-2 Microglobulin during and after Completing Chemotherapy in Marginal Zone Lymphoma

Byung Woo Yoon, Jung Yong Hong, Dok Hyun Yoon, Kyoung Min Lee, Shin Kim, Jung Sun Park, Chan-Sik Park, Jooryung Huh, Chan-jeoung Park, Seongsoo Jang, Jin-Sook Ryu, Sang Wook Lee, Cheolwon Suh

Blood (2018) 132 (Supplement 1): 5335.

https://doi.org/10.1182/blood-2018-99-115781

Published: 2018

Journal Articles

Serum Beta-2 Microglobulin Predicts the Survival Outcome after Autologous Stem Cell Transplantation in Relapse or Refractory Diffuse Large B Cell Lymphoma

Hyeun-Su Im, MD, Jung Yong Hong, Dok Hyun Yoon, Shin Kim, Jung Sun Park, Sang Wook Lee, Chan-Sik Park, Jin-Sook Ryu, Jooryung Huh, Cheolwon Suh

Blood (2018) 132 (Supplement 1): 5755.

https://doi.org/10.1182/blood-2018-99-120334

Published: 2018

Journal Articles

High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation As a Salvage Treatment in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Jaewon Hyung, MD, Jung Yong Hong, MD, Dok Hyun Yoon, Shin Kim, Jung Sun Park, Chan-Sik Park, Sang Wook Lee, Jin-Sook Ryu, Jooryung Huh, Cheolwon Suh

Blood (2018) 132 (Supplement 1): 5762.

https://doi.org/10.1182/blood-2018-99-118222

Published: 2018

Journal Articles

Increased Serum Beta-2 Microglobulin during Induction Chemotherapy Associated with Poor Prognosis in Primary Central Nervous System Lymphoma

Jaewon Hyung, MD, Jung Yong Hong, MD, Dok Hyun Yoon, Shin Kim, Jung Sun Park, Chan-Sik Park, Sang Wook Lee, Jin-Sook Ryu, Jooryung Huh, Cheolwon Suh

Blood (2018) 132 (Supplement 1): 2995.

https://doi.org/10.1182/blood-2018-99-118221

Published: 2018

Journal Articles

Low Relapse Rate after 2 Years in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP and Achieved Complete Response

Junho Kang, MD, Kyoungmin Lee, MD, Jung Yong Hong, Dok Hyun Yoon, Shin Kim, Jung Sun Park, Sang Wook Lee, Chan-Sik Park, Jin-Sook Ryu, Jooryung Huh, Cheolwon Suh

Blood (2018) 132 (Supplement 1): 2996.

https://doi.org/10.1182/blood-2018-99-119922

Published: 2018

Journal Articles

Salvage Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Jaewon Hyung, MD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Kyoungmin Lee, MD, Shin Kim, RN, Chan-Sik Park, Jooryung Huh, MD PhD, Jin-Sook Ryu, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 5506.

https://doi.org/10.1182/blood.V130.Suppl_1.5506.5506

Published: 2017

Journal Articles

Thiotepa, Busulfan, and Cyclophosphamide and Busulfan, Cyclophosphamide, Etoposide As Autologous Stem Cell Transplantation Conditioning Regimen in Primary Central Nervous System Lymphoma

Jaewon Hyung, MD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Kyoungmin Lee, MD, Shin Kim, RN, Chan-Sik Park, Jooryung Huh, MD PhD, Jin-Sook Ryu, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 3300.

https://doi.org/10.1182/blood.V130.Suppl_1.3300.3300

Published: 2017

Journal Articles

Adding Beta-2 Microglobulin for Better Prognostication of Primary Central Nervous System Lymphoma

Jaewon Hyung, MD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Kyoungmin Lee, MD, Shin Kim, RN, Chan-Sik Park, Jooryung Huh, MD PhD, Jin-Sook Ryu, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 4139.

https://doi.org/10.1182/blood.V130.Suppl_1.4139.4139

Published: 2017

Journal Articles

The Absolute Lymphocyte Count Is Associated with the Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified

Byeong Seok Sohn, MDPhD, Jeongseok Kim, MD, Dok Hyun Yoon, MD PhD, Shin Kim, RN, Jooryung Huh, MD PhD, Sung-En Park, MD, Young Jin Yuh, MD PhD, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 2803.

https://doi.org/10.1182/blood.V130.Suppl_1.2803.2803

Published: 2017

Journal Articles

The Efficacy of Systemic High Dose Methotrexate As Central Nervous System Prophylaxis in Patients with High Risk Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Analysis

Kyoungmin Lee, MD, Dok Hyun Yoon, MD PhD, Jung Yong Hong, Jung Bok Lee, PhD, Shin Kim, RN, Jung Sun Park, MSc, Jooryung Huh, MD PhD, Sang Wook Lee, MD, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 4130.

https://doi.org/10.1182/blood.V130.Suppl_1.4130.4130

Published: 2017

Journal Articles

Prognostic Significance of Beta-2 Microglobulin in Patients with Diffuse Large B Cell Lymphoma in Rituximab Era

Seyoung Seo, Dok Hyun Yoon, Changhoon Yoo, Yumun Jeong, Ji Hyun Park, Shin Kim, R.N, Jooryung Huh, Cheolwon Suh

Blood (2014) 124 (21): 2982.

https://doi.org/10.1182/blood.V124.21.2982.2982

Published: 2014

Journal Articles

A New Prognostic Index for Multiple Myeloma Patients in the Era of Novel Agents

Hyungwoo Cho, Cheolwon Suh, Dok Hyun Yoon, Ji Hyun Park, Shin Kim, Sang-wook Lee, Chan-Sik Park, MD, Jooryung Huh, Kyoungmin Lee, Eun Hee Kang, Jung Sun Park, Chan-Jeoung Park, Jin Seok Kim, MD, PhD, Kihyun Kim

Blood (2014) 124 (21): 3472.

https://doi.org/10.1182/blood.V124.21.3472.3472

Published: 2014

Journal Articles

Clinical Outcomes of R-CHOP Chemotherapy Alone Compared with R-CHOP Plus Radiotherapy in Patients with Localized, Non-Bulky Diffuse Large B-Cell Lymphoma

Blood (2014) 124 (21): 4421.

https://doi.org/10.1182/blood.V124.21.4421.4421

Published: 2014

Journal Articles

Proposal of New Prognostic Index for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era

Shinkyo Yoon, MD, Dok Hyun Yoon, MD, Shin Kim, Kyoungmin Lee, Eun Hee Kang, Sang-wook Lee, Chan-Jeoung Park, MD PhD, Chan-Sik Park, MD, Jooryung Huh, Cheolwon Suh

Blood (2014) 124 (21): 1668.

https://doi.org/10.1182/blood.V124.21.1668.1668

Published: 2014

Journal Articles

Thiotepa Containing Regimen As Conditioning Chemotherapy for Lymphoma Involving Central Nervous System Compared with BuCyE (Busulfan, Cyclophosphamide and Etoposide)

Yi Rang Kim, Dok Hyun Yoon, Shin Kim, Kyoungmin Lee, Eun Hee Kang, Jung Sun Park, Changhoon Yoo, Jeong-eun Kim, Jae-Cheol Jo, Jooryung Huh, Jeong Hoon Kim, Sang-wook Lee, Cheolwon Suh

Blood (2014) 124 (21): 1190.

https://doi.org/10.1182/blood.V124.21.1190.1190

Published: 2014

Journal Articles

Prognostic Impact Of Beta-2 Microglobulin In Patients With Non-Gastric Marginal Zone Lymphoma

Changhoon Yoo, M.D, Dok Hyun Yoon, MD, Shin Kim, RN, Jooryung Huh, MD, Chan-Jeoung Park, MD, Sang-wook Lee, MD, Cheolwon Suh

Blood (2013) 122 (21): 4297.

https://doi.org/10.1182/blood.V122.21.4297.4297

Published: 2013

NARROW

Validation of Angioimmunoblastic T-Cell Lymphoma (AITL) Score in Korean AITL Patients

Prognostic Stratification of Patients with Primary Central Nervous System Lymphoma Using Serum β 2 -Microglobulin Levels

Central Nervous System Relapse in Patients with Extranodal NK/T-Cell Lymphoma, Nasal Type

Central Nervous System Relapse in Patients with Peripheral T-Cell Lymphoma

Prognostic Value of Serum Beta-2 Microglobulin during and after Completing Chemotherapy in Marginal Zone Lymphoma

Serum Beta-2 Microglobulin Predicts the Survival Outcome after Autologous Stem Cell Transplantation in Relapse or Refractory Diffuse Large B Cell Lymphoma

High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation As a Salvage Treatment in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Increased Serum Beta-2 Microglobulin during Induction Chemotherapy Associated with Poor Prognosis in Primary Central Nervous System Lymphoma

Low Relapse Rate after 2 Years in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP and Achieved Complete Response

Salvage Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Thiotepa, Busulfan, and Cyclophosphamide and Busulfan, Cyclophosphamide, Etoposide As Autologous Stem Cell Transplantation Conditioning Regimen in Primary Central Nervous System Lymphoma

Adding Beta-2 Microglobulin for Better Prognostication of Primary Central Nervous System Lymphoma

The Absolute Lymphocyte Count Is Associated with the Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified

The Efficacy of Systemic High Dose Methotrexate As Central Nervous System Prophylaxis in Patients with High Risk Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Analysis

Prognostic Significance of Beta-2 Microglobulin in Patients with Diffuse Large B Cell Lymphoma in Rituximab Era

A New Prognostic Index for Multiple Myeloma Patients in the Era of Novel Agents

Clinical Outcomes of R-CHOP Chemotherapy Alone Compared with R-CHOP Plus Radiotherapy in Patients with Localized, Non-Bulky Diffuse Large B-Cell Lymphoma

Proposal of New Prognostic Index for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era

Thiotepa Containing Regimen As Conditioning Chemotherapy for Lymphoma Involving Central Nervous System Compared with BuCyE (Busulfan, Cyclophosphamide and Etoposide)

Prognostic Impact Of Beta-2 Microglobulin In Patients With Non-Gastric Marginal Zone Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only